Never miss a story

Get subscribed to our newsletter


×
Office building of Infosys. Pixabay

Software major Infosys on Wednesday launched blockchain-powered distributed applications (apps) for government services, insurers and supply chain management verticals.

“The applications are designed as ready-to-subscribe business networks to ensure quick deployment, inter-operability across disparate systems of value chain stakeholders and cases involving analytics and IoT (Internet of Things),” the-city based IT firm said in a statement.


A blockchain is a list of records, called blocks, that are linked using cryptography. Each block contains a cryptographic hash of the previous block, a timestamp and transaction data.

“Our applications are equipped with predictive RoI (return on investment) analytics for business investments that can be tailored to meet industry-specific needs,” Infosys said in the statement.

Global enterprises can capitalise on blockchain’s benefits of trust, immutability, and transparency to develop an inter-organisational conduit for strengthening their core business processes across multiple value chain partners having disparate IT systems, it said.


Employees queue up infront of Infosys office. Wikimedia Commons

The supply chain application leverages the blockchain platform to offer solutions for inbound/outbound logistics and distribution activities.

“The application can be integrated with the systems and IoT devices while ensuring 24×7 transaction security between stakeholders within a supply chain,” Infosys said.

Also Read: Tech Giants Amazon, Apple, Google Bat for Universal Smart Home Standard

The government services application enables state-run organisations to establish inter-departmental interaction, collaboration, data sharing, network transparency and defined workflows – to fulfil citizen-centric service requests, through a single window.

“Our insurance application is designed to aid insurance firms in policy administration, claims handling, multi-party negotiation, usage-based policy pricing and parametric insurance activities,” the statement added.

The modular, scalable and customisable application can be integrated with the enterprise systems and IoT networks. (IANS)


Popular

Photo by Alexander Shatov on Unsplash

Twitter has confirmed that its algorithms amplify right-leaning political content.

By Nikhila Natarajan

In a continuing study on the effects of machine learning (ML) on public conversation, Twitter has confirmed that its algorithms amplify right-leaning political content. "In six out of seven countries - all but Germany - tweets posted by accounts from the political right receive more algorithmic amplification than the political left when studied as a group," Twitter blogged.

"Right-leaning news outlets, as defined by the independent organisations, see greater algorithmic amplification on Twitter compared to left-leaning news outlets." Since 2016, Twitter users are able to choose between viewing algorithmically ordered tweets first in their home timeline or viewing the most recent tweets in reverse chronological order.

"An algorithmic home timeline displays a stream of tweets from accounts we have chosen to follow on Twitter, as well as recommendations of other content Twitter thinks we might be interested in based on accounts we interact with frequently, tweets we engage with, and more. "As a result, what we see on our timeline is a function of how we interact with Twitter's algorithmic system, as well as how the system is designed."

The new research is based on tweets of elected officials of House of Commons members in Canada, the French National Assembly, the German Bundestag, House of Representatives in Japan, Congress of Deputies of Spain, House of Commons in the UK, and official and personal accounts of House of Representatives and Senate members in the US, as well as news outlets, from April 1 to August 15, 2020.

gold Apple iPhone 6s displaying Twitter logo Tweets about political content from elected officials, regardless of party or whether the party is in power, do see algorithmic amplification when compared to political content on the reverse chronological timeline. | Photo by Sara Kurfeß on Unsplash

Keep Reading Show less
Flickr

Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal.

Even as India celebrates reaching a milestone of 100 crore Covid vaccine doses, Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal. In a video shared on his Facebook and Twitter page, Bansal hailed Sonu Kumar as a "citizen celebrity".

Bansal said that Kumar not only helped "just co-workers and family but complete strangers too. With patience, empathy and uncanny jugaad". He added that Kumar joined him "many moons ago" and completed his open school from a parking lot.

"Education has helped this wonderful man enable others to get India back on track. Bravo! The CoWin portal on Thursday mentioned that a total of 100 crore vaccine doses has been administered so far to the eligible population under the vaccination drive in India, nine months after the nationwide inoculation programme was started to protect the people against Covid-19.

"It's a cause of significant celebration and happiness," Bansal said in the video. He said that while people just help a few around them, Kumar "bridged the digital gap" for 64 people, who were finding it difficult to register themselves online on the vaccine portal. Kumar said he doesn't feel that he has contributed much towards the 100 crore vaccine dose count. "I have been able to help only 64 people, if I was able to help more I would have been happier." (IANS/ MBI)


Keep Reading Show less
VOA

A health worker counts antiretroviral drug tablets for a patient at The AIDS Support Organization (TASO) in the capital Kampala, Uganda, July 12, 2012.

KAMPALA, UGANDA — Uganda has kickstarted a trial for the injectable HIV drugs cabotegravir and rilpivirine. Researchers and those living with HIV say the trial will likely end pill fatigue, fight stigma, improve adherence and ensure patients get the right dosage.

The two drugs have been in use as tablets. The World Health Organization last year licensed their use as injectables.

Keep reading... Show less